EVO
Athens
About EVO
EVO develops AI-powered bioengineering solutions for athletes and health care providers. They provide personalised performance monitoring, myoskeletal analysis, and sports performance through injury incident prediction and minimization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.3M
- Funding stage: Seed
- Last round: Seed (Sep 2024)
- Website: evo4hp.com
Industries & Categories
Artificial Intelligence (AI), Information Technology, Software
Social Profiles
Canonical: https://fsome.com/organization/evo-27347 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.